Univest
Univest
  • Markets

Hexagon Nutrition Shares Make Decent Market Debut at 7% Listing Premium — LTP Rises Further to Rs 50.66; Should You Buy, Sell or Hold?

  • June 12, 2026
  • Posted by: Ankit Jaiswal
  • Category: IPO
No Comments
Hexagon Nutrition Shares Make Decent Market Debut at 7%

Hexagon Nutrition IPO: Issue price Rs 45. Listed June 12, 2026 on NSE (BE series). Listing open: Rs 48.25 (+7.22%). LTP: Rs 50.66 (+12.58% from issue price). Day high Rs 50.66, Day low Rs 48.10. Circuit: Upper Rs 90, Lower Rs 22.50. BE series: compulsory delivery, no intraday squaring off.

Hexagon Nutrition made its stock market debut on NSE today, June 12, 2026, opening at Rs 48.25 , a listing premium of 7.22% over the IPO issue price of Rs 45. The listing was in line with the pre-listing grey market premium (GMP) that had signalled a 7-9% listing gain. Since the opening, the Hexagon Nutrition IPO listing price has moved up further to Rs 50.66 (the current day high and LTP), representing a gain of approximately 12.6% from the IPO issue price. Hexagon Nutrition is trading on NSE in the BE (Trade-to-Trade) series, meaning all transactions require compulsory delivery with no facility for intraday squaring off. The upper circuit for today is Rs 90 and the lower circuit is Rs 22.50. The key question for Hexagon Nutrition IPO allottees and prospective buyers today is: should you buy, sell, or hold at current levels?

Click Here – Get Free Research From Univest

Table of Contents

Toggle
  • Hexagon Nutrition Listing Day Data
  • Buy, Sell or Hold: Our View on Hexagon Nutrition After Listing
  • What is Hexagon Nutrition?
  • Conclusion
  • Frequently Asked Questions
    • What was the Hexagon Nutrition IPO listing price today?
    • Should you buy, sell or hold Hexagon Nutrition after listing?
    • What does BE series mean for Hexagon Nutrition shares?
    • What is the circuit limit for Hexagon Nutrition shares today?

Hexagon Nutrition Listing Day Data

Parameter Value
IPO Issue Price Rs 45 per share
Listing Open Price Rs 48.25 (+7.22% over issue price)
Current LTP (June 12) Rs 50.66
Gain from IPO Price Rs 5.66 per share (+12.58%)
Today’s High Rs 50.66 (= LTP, at day’s high)
Today’s Low Rs 48.10
Exchange / Series NSE BE (Trade-to-Trade / compulsory delivery)
Settlement Compulsory delivery , no intraday squaring off
Upper Circuit Rs 90.00 (2x issue price)
Lower Circuit Rs 22.50 (0.5x issue price)
GMP Signal (pre-listing) Rs ~3 (+7%) , accurate vs actual listing
Buy/Sell/Hold View Partial profit-booking recommended at current levels; hold rest with SL Rs 47

Track Hexagon Nutrition IPO Listing and All SME IPOs on Univest

Univest covers Hexagon Nutrition and all SME IPO listings with live data and analysis.

  • Live Hexagon Nutrition IPO listing price and volume tracking
  • SME IPO listing day analysis and buy/sell/hold recommendations
  • All active IPO GMP and post-listing data from Univest

See the Stocks →

Buy, Sell or Hold: Our View on Hexagon Nutrition After Listing

For Hexagon Nutrition IPO allottees sitting on a listing gain of 12.6% from the Rs 45 issue price, a staggered approach makes the most sense on listing day. Consider booking 50-60% of your position at or near the current Rs 50.66 level to lock in a meaningful double-digit listing gain. Hold the remaining shares with a stop loss at Rs 47 (below the listing open of Rs 48.25) to participate in any further upside if buying momentum continues through the session. For those who missed the IPO allotment and are considering buying in the secondary market, the BE (Trade-to-Trade) series requires you to be prepared for compulsory delivery , you cannot buy and sell on the same day. Only buy if you have a clear 1-2 week holding plan and conviction in the company’s fundamentals.

What is Hexagon Nutrition?

Hexagon Nutrition is an Indian nutritional products manufacturer that listed its shares today via an SME IPO on NSE. The company focuses on the nutraceuticals, nutritional supplements, and health food segment, which is a high-growth sector in India driven by increasing health consciousness and preventive healthcare awareness. The Hexagon Nutrition IPO was priced at Rs 45 per share with the proceeds intended for business expansion and working capital. The decent listing at 7% premium reflects moderate but positive investor sentiment toward the nutritional products sector.

Track Hexagon Nutrition IPO and All SME Listings on Univest

Conclusion

The Hexagon Nutrition IPO has made a decent debut with a 7% listing premium at Rs 48.25, rising further to Rs 50.66 (+12.6%). Allottees should consider partial profit-booking at current levels. Track live Hexagon Nutrition IPO listing data on Univest.

Download the Univest iOS App or Univest Android App to track Hexagon Nutrition IPO listing price and all SME IPO data live on Univest.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What was the Hexagon Nutrition IPO listing price today?

Ans. Hexagon Nutrition shares listed on NSE today, June 12, 2026, at an opening price of Rs 48.25, representing a 7.22% premium over the IPO issue price of Rs 45. This is in line with the pre-listing grey market premium (GMP) that had signalled a 7-9% listing gain. Since the opening, the stock has moved up further to Rs 50.66 (the day’s high and current LTP), representing a gain of approximately 12.6% from the IPO issue price of Rs 45. The stock is trading on the NSE in the BE (Trade-to-Trade) series with compulsory delivery settlement.

Should you buy, sell or hold Hexagon Nutrition after listing?

Ans. For IPO allottees who received shares at the issue price of Rs 45 and are currently sitting on a gain of approximately 12.6% at Rs 50.66, a partial sell at current levels is a prudent approach on listing day. Booking 50-60% of the position locks in a meaningful listing gain, while holding the remainder allows participation in any further upside. For those who did not receive IPO allotment, buying on listing day in the BE (Trade-to-Trade) series requires caution as the settlement is compulsory delivery (no intraday squaring off), which increases risk. The stock should ideally be bought only if you are comfortable with a 2-3 week holding period. A suggested stop loss for holders is Rs 47 (below the listing open).

What does BE series mean for Hexagon Nutrition shares?

Ans. Hexagon Nutrition shares are trading in the BE (trade-for-trade) series on NSE, which means all transactions are treated as compulsory delivery , you cannot buy and sell on the same day to square off a position. Every purchase of Hexagon Nutrition shares requires full payment upfront and results in shares being credited to your demat account. Similarly, every sale requires the shares to be in your demat account. This settlement mechanism is applied to freshly listed SME stocks for the initial period (typically 10 trading days after listing) to reduce speculative activity and ensure delivery-based transactions. Investors considering buying Hexagon Nutrition on listing day must be prepared to take delivery of shares.

What is the circuit limit for Hexagon Nutrition shares today?

Ans. The circuit limits for Hexagon Nutrition shares on the listing day are: upper circuit Rs 90 (double the issue price of Rs 45) and lower circuit Rs 22.50 (half the issue price). These 100%/50% circuit bands are standard for freshly listed SME IPO stocks in the BE series. The current LTP of Rs 50.66 is well within these limits, and the stock has not hit either circuit limit today. If the stock were to move significantly on heavy institutional interest, it could theoretically trade up toward Rs 90 (upper circuit), but at current moderate volumes, the stock is trading in a rational range close to its listing premium.



listing Market Debut
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply